Genetic test for heart disease nears launch
This article was originally published in Clinica
A genetic susceptibility test for heart disease could be available in the US within a year. Medical Science Systems of Newport Beach, California, has linked up with the Mayo Clinic in Rochester, Minnesota, to determine how the genetic marker identified by the test interacts with other factors to produce heart disease. The marker is known to influence the inflammatory component of the disease.
You may also be interested in...
India’s Sun Pharma has been denied leave to appeal against a US court decision rejecting the company’s bid for dismissal of a multi-district antitrust lawsuit.
Former Sandoz executive Hector Armando Kellum has admitted involvement in a US generic price-fixing conspiracy, the US Department of Justice has announced.
The last year of the run up to the full implementation of the MDR has been characterized by a flurry of new documents and measures, but industry is adamant that medtech is heading for a crisis that will impact industry and patients alike.